BiaCure Therapies Secures SBIR Phase I Grant for High-Frequency Energy Treatment of Nail Fungus BiaCure Therapies has been awarded a $2.6 million SBIR Phase I grant to advance its high-frequency energy technology to treat onychomycosis, showing promise for effective, non-invasive solutions.

BiaCure Therapies Secures SBIR Phase I Grant for High-Frequency Energy Treatment of Nail Fungus #USA #BiaCure #Onychomycosis #High-Frequency_Energy #Pewaukee

Laura King Elevates BiaCure’s Impact as New Tactile Medical Board Member Laura King, BiaCure CEO, has been appointed to Tactile Medical's Board of Directors, enhancing her commitment to improving patient care in chronic condition treatments.

Laura King Elevates BiaCure’s Impact as New Tactile Medical Board Member #USA #Laura_King #Tactile_Medical #BiaCure #Pewaukee,_Wisconsin